0001520138-23-000062.txt : 20230118 0001520138-23-000062.hdr.sgml : 20230118 20230118165551 ACCESSION NUMBER: 0001520138-23-000062 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221123 FILED AS OF DATE: 20230118 DATE AS OF CHANGE: 20230118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROGICH SIGMUND CENTRAL INDEX KEY: 0001168218 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39015 FILM NUMBER: 23534985 MAIL ADDRESS: STREET 1: C/O BIOVIE STREET 2: 2120 COLORADO AVENUE, SUITE 230 CITY: SANTA MONICA STATE: CA ZIP: 90404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOVIE INC. CENTRAL INDEX KEY: 0001580149 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462510769 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 680 W NYE LANE STREET 2: SUITE 201 CITY: CARSON CITY STATE: NV ZIP: 89703 BUSINESS PHONE: 775-888-3162 MAIL ADDRESS: STREET 1: 680 W NYE LANE STREET 2: SUITE 201 CITY: CARSON CITY STATE: NV ZIP: 89703 FORMER COMPANY: FORMER CONFORMED NAME: NANOANTIBIOTICS, INC. DATE OF NAME CHANGE: 20130625 4 1 ownership.xml X0306 4 2022-11-23 0 0001580149 BIOVIE INC. BIVI 0001168218 ROGICH SIGMUND C/O BIOVIE INC. 680 W NYE LANE STE 201 CARSON CITY NV 89703 1 0 0 0 STOCK OPTION (RIGHT TO BUY) 6.12 2022-11-23 4 A 0 55000 0 A 2032-11-23 COMMON STOCK 55000 55000 D Options granted pursuant to the Company's 2019 Omnibus Equity Incentive Plan. The options vest in four equal installments over a one-year period ending November 9, 2023. /S/ SIGMUND ROGICH 2023-01-13